Showing results (51-60 of 365) with videos related to
Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|March 4, 2016
α-Fetoprotein level-dependent early hepatitis B surface antigen decline during entecavir therapy in chronic hepatitis B with hepatitis flareWen-Juei Jeng, Yi-Cheng Chen, Ming-Ling Chang, et al.The American Journal of Gastroenterology|July 2, 2025
Switching to entecavir >3 months before the end of tenofovir-based therapy in HBeAg-negative patients may reduce early relapse and hepatitis flareYi-Cheng Chen, Wen-Juei Jeng, Rong-Nan Chien, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 25, 2018
Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patientsYing-Chieh Chen, Wei Teng, Yi-Chung Hsieh, et al.Scientific Reports|November 12, 2017
Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interactionChing-Chih Hu, Wen-Juei Jeng, Yi-Cheng Chen, et al.American Journal of Cancer Research|November 12, 2021
Complete response at first transarterial chemoembolization predicts favorable outcome in hepatocellular carcinomaChien-Wei Peng, Wei Teng, Kar-Wai Lui, et al.Scientific Reports|June 26, 2023
Efficacy of a multidimensional self-management intervention on low-education women with metabolic syndrome: a cluster randomized controlled trialShu-Hung Chang, Yi-Ya Chang, Wen-Juei Jeng, et al.European Journal of Gastroenterology & Hepatology|December 19, 2019
Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: a real-world experiencePo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 10, 2019
The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patientsPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.American Journal of Cancer Research|August 6, 2021
MELD score is the better predictor for 30-day mortality in patients with ruptured hepatocellular carcinoma treated by trans-arterial embolizationYa-Ting Cheng, Wei Teng, Kar-Wai Lui, et al.Medicine|June 27, 2022
One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B: An observational studyYi-Cheng Chen, Chao-Wei Hsu, Rong-Nan Chien, et al.Pageof 37